Latest HPV-positive oropharyngeal cancer Stories
Medical and dental centers throughout U.S.
LOS ANGELES, Dec. 23, 2014 /PRNewswire/ -- The Farrah Fawcett Foundation, created by Ms.
SAN DIEGO, Aug. 20, 2014 /PRNewswire/ -- Trovagene, Inc.
Physicians at Johns Hopkins have developed blood and saliva tests that help accurately predict recurrences of HPV-linked oral cancers in a substantial number of patients.
There are currently 148 known strains of the human papillomavirus, and a new study led by NYU Langone Medical Center reveals that 69 percent of otherwise healthy US adults are infected with one or more strains.
A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against treatment-resistant head-and-neck squamous cell cancers.
Patients with cancer of the throat and who are positive for the Human Papilloma virus (HPV+) have a good prognosis, but until now the effect of being HPV+ on the prognosis of tumors located elsewhere in the head and neck was unknown.
Xpert HPV is the Only Test Capable of Reporting High-risk Human Papillomavirus DNA in Captured Cervical Cells SUNNYVALE, Calif., April 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD)
A new study, published in the Journal of Clinical Oncology on June 17, 2013 showed that 33% of all throat cancer cases may be caused by HPV infection.
Michael Douglas raised the prospect of oral sex leading to throat cancer through the transmission of the human papillomavirus (HPV), a virus known to cause the disease in some individuals.